Market Tracker

07/24 3:19pm ET

Repligen Corp (NASDAQ:RGEN)

23.01
Data as of 3:03pm ET
 -0.67 / -2.83%
Today’s Change
9.41
Today|||52-Week Range
24.68
+68.70%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close23.68
Today’s open23.70
Day’s range22.98 - 23.70
Volume209,165
Average volume (3 months)521,757
Market cap$758.7M
Dividend yield--
Data as of 3:03pm ET, 07/24/2014

Growth & Valuation

Earnings growth (last year)+11.11%
Earnings growth (this year)-46.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+9.48%
P/E ratio41.8
Price/Sales6.34
Price/Book7.28

Competitors

 Today’s
change
Today’s
% change
RVNCRevance Therapeutics...+0.08+0.25%
ENTAEnanta Pharmaceutica...-0.58-1.48%
NDZNordion Inc0.000.00%
OMEDOncoMed Pharmaceutic...-0.69-2.86%
Data as of 3:04pm ET, 07/24/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)$0.06
Annual revenue (last year)$68.2M
Annual profit (last year)$16.1M
Net profit margin23.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Treasurer, Director &
CAO
Walter C. Herlihy
Senior Vice President-
Global Operations
Daniel P. Witt
Corporate headquarters
Waltham, Massachusetts

Forecasts